Last reviewed · How we verify

NCT05715151

Continuous Quality Improvement Cohorts on Advanced Access

Status unknown NA Last updated 6 February 2023
What this trial tests

NA trial testing CQI intervention in Primary Health Care in 48 participants. Status unknown.

Timeline
21 September 2022
Primary endpoint
1 June 2024
1 June 2025

Quick facts

Lead sponsorUniversité de Sherbrooke
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment48
Start date21 September 2022
Primary completion1 June 2024
Estimated completion1 June 2025
Sites18 locations across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Université de Sherbrooke — full company profile →

Who can join

18 and older, any sex, with Primary Health Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to compare the implementation and effects of CQI cohorts on AA for PHC clinics. The main questions it aims to answer are to assess the effectiveness of CQI cohorts on AA outcomes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Impact of externally facilitated continuous quality improvement cohorts on Advanced Access to support primary healthcare teams: protocol for a quasi-randomized cluster trial.
    Breton M, Gaboury I, Martin E, Green ME, et al · · 2023 · cited 5× · PMID 37038126 · DOI 10.1186/s12875-023-02048-y

Verify or expand the search:

Other recruiting trials for Primary Health Care

Currently open trials in the same condition.

Other Université de Sherbrooke trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05715151.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing